Text Size
2 studies found for:    12895417 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Multicenter Study of NAP (AL-108) in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AL-108;   Drug: Placebo
2 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
To Top

† Indicates status has not been verified in more than two years